A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus
Public ClinicalTrials.gov record NCT06628362. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of Once-Weekly CT-388 Administered Subcutaneously for 48 Weeks to Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multi-center, randomized, double-blind, placebo-controlled, parallel group dose-finding study to evaluate the efficacy and safety of enicepatide at low, middle, and high doses in participants who are overweight or obese with Type 2 diabetes mellitus (T2DM).
Study identification
- NCT ID
- NCT06628362
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 447 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 20, 2024
- Primary completion
- May 28, 2026
- Completion
- Sep 23, 2026
- Last update posted
- Jun 23, 2026
2024 – 2026
United States locations
- U.S. sites
- 52
- U.S. states
- 21
- U.S. cities
- 48
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Central Alabama Research | Birmingham | Alabama | 35209-8401 | — |
| University of Alabama at Birmingham (UAB) | Birmingham | Alabama | 35233 | — |
| Lakeview Clinical Research, LLC | Guntersville | Alabama | 35976 | — |
| Yuma Clinical Trials | Yuma | Arizona | 85364 | — |
| AMCR Institute | Escondido | California | 92025 | — |
| Ark Clinical-Fountain Valley | Fountain Valley | California | 92708 | — |
| Orange Country Research Center | Lake Forest | California | 92630 | — |
| Ark Clinical Research | Long Beach | California | 90806 | — |
| Catalina Research Institute, LLC | Montclair | California | 91763 | — |
| Asclepes Research Centers | Sherman Oaks | California | 91403 | — |
| Encompass Clinical Research | Spring Valley | California | 91978 | — |
| Flourish Research - Boca Raton | Boca Raton | Florida | 33434 | — |
| Tampa Bay Medical Research | Clearwater | Florida | 33761 | — |
| K2 Medical Research, LLC - Maitland | Maitland | Florida | 32751 | — |
| K2 Medical Research, LLC - Orlando | Maitland | Florida | 32751 | — |
| Flourish Research Acquisition, LLC | Miami | Florida | 33138 | — |
| K2 Medical Research, LLC - South Orlando | Orlando | Florida | 32806 | — |
| Aging Well Associates | St. Petersburg | Florida | 33713 | — |
| K2 Medical Research Tampa | Tampa | Florida | 33607 | — |
| K2 Summit Research | The Villages | Florida | 32159 | — |
| Privia Medical Group Georgia, LLC | Fayetteville | Georgia | 30214 | — |
| Privia Medical Group Georgia - Thomasville | Thomasville | Georgia | 31792 | — |
| Rophe Adult and Pediatric Medicine/SKYCRNG | Union City | Georgia | 30291 | — |
| Duly Health and Care | Lombard | Illinois | 60148 | — |
| McFarland Clinic | Ames | Iowa | 50010 | — |
| Cotton O'Neil Clinical Research Center | Topeka | Kansas | 66606 | — |
| NOLA Cares, LLC | Metairie | Louisiana | 70006 | — |
| Flourish Research Acquisition, LLC dba Flourish Bowie | Bowie | Maryland | 20715 | — |
| Centennial Medical Group | Elkridge | Maryland | 21075 | — |
| NECCR PrimaCare Research LLC | Fall River | Massachusetts | 02721 | — |
| Olive Branch Family Medical Center; Family Medicine | Olive Branch | Mississippi | 38654 | — |
| SKY Integrative Medical Center/SKYCRNG | Ridgeland | Mississippi | 39157 | — |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198 | — |
| Ellipsis Research Group | Brooklyn | New York | 11215 | — |
| Accellacare of Cary | Cary | North Carolina | 27518 | — |
| Accellacare - Hickory | Hickory | North Carolina | 28601 | — |
| Accellacare of Rocky Mount | Rocky Mount | North Carolina | 27804 | — |
| Accellacare of Piedmont Healthcare | Statesville | North Carolina | 28625 | — |
| Accellacare of Wilmington, LLC | Wilmington | North Carolina | 28401 | — |
| Accellacare Research of Winston Salem | Winston-Salem | North Carolina | 27103 | — |
| Diabetes and Endocrinology Associates of Stark County, Inc. | Canton | Ohio | 44718 | — |
| Tekton Research | Edmond | Oklahoma | 73013 | — |
| Roper St. Francis Physician Partners - Primary Care | Mt. Pleasant | South Carolina | 29464 | — |
| Norwood Family Medicine | Knoxville | Tennessee | 37912 | — |
| Summit-Halls Family Practice | Knoxville | Tennessee | 37938 | — |
| FutureSearch Trials of Neurology | Austin | Texas | 78731 | — |
| Velocity Clinical Research - Dallas | Dallas | Texas | 75230 | — |
| University of Texas Southwestern Medical Center Investigation Drug Services | Dallas | Texas | 75390 | — |
| Juno Research, LLC | Houston | Texas | 77040 | — |
| Consano Clinical Research | Shavano Park | Texas | 78231 | — |
| Privia Medical Group North Texas - Stephenville | Stephenville | Texas | 76401 | — |
| Manassas Clinical Research Center | Manassas | Virginia | 20110 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06628362, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 23, 2026 · Synced Sep 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06628362 live on ClinicalTrials.gov.